Joseph Pantginis
Stock Analyst at HC Wainwright & Co.
(1.22)
# 3,380
Out of 4,783 analysts
800
Total ratings
29.25%
Success rate
-12.88%
Average return
Main Sectors:
Stocks Rated by Joseph Pantginis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LXRX Lexicon Pharmaceuticals | Reiterates: Buy | $4 | $0.64 | +528.24% | 21 | Mar 28, 2025 | |
| XOMA XOMA Royalty | Reiterates: Buy | $104 | $20.80 | +400.00% | 23 | Mar 28, 2025 | |
| TPST Tempest Therapeutics | Maintains: Buy | $47 → $16 | $0.79 | +1,924.29% | 18 | Mar 28, 2025 | |
| PDSB PDS Biotechnology | Maintains: Buy | $21 → $13 | $1.28 | +919.61% | 30 | Mar 27, 2025 | |
| STTK Shattuck Labs | Reiterates: Neutral | n/a | $1.06 | - | 18 | Mar 27, 2025 | |
| ATNM Actinium Pharmaceuticals | Reiterates: Buy | $4 | $1.84 | +117.39% | 27 | Mar 27, 2025 | |
| VKTX Viking Therapeutics | Reiterates: Buy | $102 | $25.71 | +296.73% | 30 | Mar 26, 2025 | |
| BMEA Biomea Fusion | Reiterates: Buy | $40 | $2.36 | +1,598.51% | 27 | Mar 25, 2025 | |
| CLNN Clene | Reiterates: Buy | $31 | $3.20 | +868.75% | 30 | Mar 25, 2025 | |
| PHAR Pharming Group | Reiterates: Buy | $37 | $8.72 | +324.17% | 17 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $1.52 | +952.63% | 27 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $3.37 | - | 8 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $77 | $11.22 | +586.58% | 21 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $2.45 | +349.90% | 7 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.31 | +3,164.77% | 2 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $35 | $3.10 | +1,030.86% | 7 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $5.84 | +174.21% | 19 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $4.1 | $4.04 | +1.61% | 18 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $0.49 | +1,731.50% | 11 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $5 | $0.65 | +668.40% | 14 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5.75 | $1.74 | +230.46% | 21 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $57 | $17.87 | +218.97% | 26 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $2.00 | +700.00% | 10 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $19.75 | +305.06% | 31 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $221 | $183.48 | +20.45% | 27 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $32 | $3.57 | +796.36% | 27 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $120 | $42.93 | +179.52% | 45 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $7.02 | +470.21% | 25 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $11 | $10.33 | +6.49% | 8 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $7 | $0.67 | +949.16% | 29 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $3.36 | +1,685.71% | 16 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $21 | $5.71 | +267.78% | 1 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $2.15 | +830.23% | 14 | Jan 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2 | $0.54 | +273.00% | 12 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.04 | +391.40% | 16 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $1.65 | +324.24% | 14 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $2.81 | +789.68% | 16 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $2.40 | +525.00% | 16 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $108.15 | - | 20 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $170 | $4.95 | +3,334.41% | 1 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $840 → $360 | $3.18 | +11,220.75% | 11 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $26 | $1.61 | +1,514.91% | 3 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $32 | $18.00 | +77.78% | 5 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $2.21 | +307.24% | 3 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $3.98 | +528.14% | 4 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $1.33 | +7,394.00% | 7 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.43 | - | 6 | Dec 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $32 | $1.56 | +1,957.88% | 4 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $30 | $2.65 | +1,032.08% | 2 | Nov 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.18 | - | 2 | Jan 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $18 → $33 | $39.05 | -15.48% | 2 | Nov 14, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 → $78 | $6.34 | +1,130.28% | 1 | Mar 24, 2017 |
Lexicon Pharmaceuticals
Mar 28, 2025
Reiterates: Buy
Price Target: $4
Current: $0.64
Upside: +528.24%
XOMA Royalty
Mar 28, 2025
Reiterates: Buy
Price Target: $104
Current: $20.80
Upside: +400.00%
Tempest Therapeutics
Mar 28, 2025
Maintains: Buy
Price Target: $47 → $16
Current: $0.79
Upside: +1,924.29%
PDS Biotechnology
Mar 27, 2025
Maintains: Buy
Price Target: $21 → $13
Current: $1.28
Upside: +919.61%
Shattuck Labs
Mar 27, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.06
Upside: -
Actinium Pharmaceuticals
Mar 27, 2025
Reiterates: Buy
Price Target: $4
Current: $1.84
Upside: +117.39%
Viking Therapeutics
Mar 26, 2025
Reiterates: Buy
Price Target: $102
Current: $25.71
Upside: +296.73%
Biomea Fusion
Mar 25, 2025
Reiterates: Buy
Price Target: $40
Current: $2.36
Upside: +1,598.51%
Clene
Mar 25, 2025
Reiterates: Buy
Price Target: $31
Current: $3.20
Upside: +868.75%
Pharming Group
Mar 21, 2025
Reiterates: Buy
Price Target: $37
Current: $8.72
Upside: +324.17%
Mar 20, 2025
Reiterates: Buy
Price Target: $16
Current: $1.52
Upside: +952.63%
Mar 20, 2025
Reiterates: Neutral
Price Target: n/a
Current: $3.37
Upside: -
Mar 20, 2025
Reiterates: Buy
Price Target: $77
Current: $11.22
Upside: +586.58%
Mar 19, 2025
Reiterates: Buy
Price Target: $11
Current: $2.45
Upside: +349.90%
Mar 18, 2025
Reiterates: Buy
Price Target: $10
Current: $0.31
Upside: +3,164.77%
Mar 14, 2025
Reiterates: Buy
Price Target: $35
Current: $3.10
Upside: +1,030.86%
Mar 11, 2025
Reiterates: Buy
Price Target: $16
Current: $5.84
Upside: +174.21%
Mar 11, 2025
Downgrades: Neutral
Price Target: $4.1
Current: $4.04
Upside: +1.61%
Mar 11, 2025
Reiterates: Buy
Price Target: $9
Current: $0.49
Upside: +1,731.50%
Mar 11, 2025
Maintains: Buy
Price Target: $18 → $5
Current: $0.65
Upside: +668.40%
Mar 6, 2025
Reiterates: Buy
Price Target: $5.75
Current: $1.74
Upside: +230.46%
Mar 5, 2025
Reiterates: Buy
Price Target: $57
Current: $17.87
Upside: +218.97%
Mar 4, 2025
Reiterates: Buy
Price Target: $16
Current: $2.00
Upside: +700.00%
Mar 3, 2025
Reiterates: Buy
Price Target: $80
Current: $19.75
Upside: +305.06%
Feb 28, 2025
Reiterates: Buy
Price Target: $221
Current: $183.48
Upside: +20.45%
Feb 28, 2025
Reiterates: Buy
Price Target: $32
Current: $3.57
Upside: +796.36%
Feb 28, 2025
Reiterates: Buy
Price Target: $120
Current: $42.93
Upside: +179.52%
Feb 27, 2025
Reiterates: Buy
Price Target: $40
Current: $7.02
Upside: +470.21%
Feb 25, 2025
Maintains: Buy
Price Target: $21 → $11
Current: $10.33
Upside: +6.49%
Feb 13, 2025
Maintains: Buy
Price Target: $17 → $7
Current: $0.67
Upside: +949.16%
Feb 12, 2025
Reiterates: Buy
Price Target: $60
Current: $3.36
Upside: +1,685.71%
Feb 4, 2025
Maintains: Buy
Price Target: $8 → $21
Current: $5.71
Upside: +267.78%
Jan 15, 2025
Reiterates: Buy
Price Target: $20
Current: $2.15
Upside: +830.23%
Jan 10, 2025
Reiterates: Buy
Price Target: $2
Current: $0.54
Upside: +273.00%
Jan 10, 2025
Reiterates: Buy
Price Target: $10
Current: $2.04
Upside: +391.40%
Dec 19, 2024
Reiterates: Buy
Price Target: $7
Current: $1.65
Upside: +324.24%
Dec 18, 2024
Reiterates: Buy
Price Target: $25
Current: $2.81
Upside: +789.68%
Dec 11, 2024
Reiterates: Buy
Price Target: $15
Current: $2.40
Upside: +525.00%
Dec 11, 2024
Reiterates: Buy
Price Target: n/a
Current: $108.15
Upside: -
Dec 9, 2024
Initiates: Buy
Price Target: $170
Current: $4.95
Upside: +3,334.41%
Nov 25, 2024
Maintains: Buy
Price Target: $840 → $360
Current: $3.18
Upside: +11,220.75%
Nov 18, 2024
Maintains: Buy
Price Target: $24 → $26
Current: $1.61
Upside: +1,514.91%
Nov 11, 2024
Maintains: Buy
Price Target: $3 → $32
Current: $18.00
Upside: +77.78%
Nov 11, 2024
Reiterates: Buy
Price Target: $9
Current: $2.21
Upside: +307.24%
Oct 2, 2024
Reiterates: Buy
Price Target: $25
Current: $3.98
Upside: +528.14%
May 16, 2024
Reiterates: Buy
Price Target: $100
Current: $1.33
Upside: +7,394.00%
Dec 1, 2021
Downgrades: Neutral
Price Target: n/a
Current: $1.43
Upside: -
Feb 25, 2021
Maintains: Buy
Price Target: $36 → $32
Current: $1.56
Upside: +1,957.88%
Nov 3, 2020
Upgrades: Buy
Price Target: $30
Current: $2.65
Upside: +1,032.08%
Jan 31, 2018
Downgrades: Neutral
Price Target: n/a
Current: $2.18
Upside: -
Nov 14, 2017
Assumes: Buy
Price Target: $18 → $33
Current: $39.05
Upside: -15.48%
Mar 24, 2017
Reiterates: Buy
Price Target: $60 → $78
Current: $6.34
Upside: +1,130.28%